Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novabay Pharmaceuticals
(NY:
NBY
)
0.6998
UNCHANGED
Streaming Delayed Price
Updated: 8:00 PM EST, Nov 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1
Open
0.6998
Bid (Size)
0.6877 (2)
Ask (Size)
0.7500 (21)
Prev. Close
0.6998
Today's Range
0.6998 - 0.6998
52wk Range
0.3611 - 11.69
Shares Outstanding
30,098,150
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals’ Proposals to Authorize the Sale of its Avenova Brand
November 15, 2024
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
NovaBay Pharmaceuticals Reports Third Quarter 2024 Financial Results
November 07, 2024
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
Performance
YTD
-89.73%
-89.73%
1 Month
+12.67%
+12.67%
3 Month
+18.63%
+18.63%
6 Month
-88.54%
-88.54%
1 Year
-93.83%
-93.83%
More News
Read More
NovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase Price
November 06, 2024
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 29, 2024
Via
Benzinga
NovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLC
October 29, 2024
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
What's Going On With NovaBay Pharmaceuticals Shares Friday?
September 20, 2024
Via
Benzinga
NBY Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of NovaBay Pharmaceuticals, Inc.’s Avenova Brand and Business Is Fair to Shareholders
September 20, 2024
From
Halper Sadeh LLC
Via
Business Wire
NovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova Assets
September 20, 2024
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
NBY Stock Earnings: NovaBay Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024
August 13, 2024
Via
InvestorPlace
NovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results
August 13, 2024
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
NovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024
August 01, 2024
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
NovaBay Pharmaceuticals Reports Record Amazon Prime Day Sales
July 30, 2024
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
What's Going On With NovaBay Pharmaceuticals (NBY) Stock?
July 29, 2024
Via
Benzinga
NovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering, Including Partial Exercise of Overallotment Option
July 29, 2024
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
S&P 500 Gains Over 1%; 3M Shares Jump After Q2 Results
July 26, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why NovaBay Pharmaceuticals (NBY) Stock Is Down 60%
July 26, 2024
Via
Benzinga
Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
July 26, 2024
Via
Benzinga
Crude Oil Down Over 2%; Bristol Myers Squibb Posts Upbeat Q2 Results
July 26, 2024
Via
Benzinga
Exposures
Fossil Fuels
Dow Surges 550 Points; Headline PCE Price Index Falls To 2.5%
July 26, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
NovaBay Pharmaceuticals Announces Pricing of $3.5 Million Underwritten Public Offering
July 26, 2024
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
July 26, 2024
Via
InvestorPlace
Why Ultra Clean Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
July 26, 2024
Via
Benzinga
NovaBay Pharmaceuticals Offers 20% Discounts on Avenova Eyecare Products During Amazon Prime Day
July 16, 2024
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
NovaBay Pharmaceuticals Reports Preliminary Second Quarter 2024 Net Revenue of $2.4 Million
July 11, 2024
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
NovaBay Pharmaceuticals and Eyenovia Commence Co-Promotion Activities
July 01, 2024
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.